SIMCERE PHARMAC. GRP LTD (S2P) — Financial Flexibility Index
SIMCERE PHARMAC. GRP LTD (S2P) has a Financial Flexibility Index of 0.54x as of December 2025. Free cash flow of €2.88 Billion (operating CF €2.01 Billion minus capex €862.20 Million) represents 1% of total liabilities (€5.31 Billion). Check S2P financial resilience to evaluate the company's liquid asset resilience ratio.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
SIMCERE PHARMAC. GRP LTD Financial Flexibility Index (2021–2025)
Historical Financial Flexibility Index trend for SIMCERE PHARMAC. GRP LTD across 5 annual periods. See S2P current assets to equity ratio to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for SIMCERE PHARMAC. GRP LTD (2021–2025)
Year-by-year free cash flow to debt coverage for SIMCERE PHARMAC. GRP LTD. For the full company profile including market capitalisation, see S2P stock market capitalisation.
| Year | Flexibility Index | Free Cash Flow (EUR) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.54x | €2.88 Billion | €2.01 Billion | €5.31 Billion | ▲ +11.7% |
| 2024 | 0.48x | €2.15 Billion | €1.39 Billion | €4.44 Billion | ▲ +55.7% |
| 2023 | 0.31x | €1.13 Billion | €151.05 Million | €3.63 Billion | ▼ -44.2% |
| 2022 | 0.56x | €2.03 Billion | €1.35 Billion | €3.64 Billion | ▲ +27354.5% |
| 2021 | 0.00x | €7.52 Million | €-201.97 Million | €3.70 Billion | — |